Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 1,032 $ 1,769
Restricted cash 7  
Accounts receivable, net 1,457 2,150
Inventories, net 7,863 7,971
Investment in marketable securities 27,007 27,929
Prepaid expenses and other current assets 1,170 1,402
Total current assets 38,536 41,221
Property and equipment, net 141 151
Equity method investment 13,005 13,325
Right of use assets 4,283 4,474
Deposits and other assets 285 285
Total assets 56,250 59,456
CURRENT LIABILITIES    
Accounts payable and accrued expenses 10,377 11,498
Operating lease liabilities 1,103 991
Other current liabilities 957 5,748
Revolving line of credit to related parties, net 600 600
Warrant derivative liabilities 1,539 38
Notes payable, current portion 4,271 3,749
Notes payable to related parties 34 193
Convertible debentures, net of discount 7,594 7,015
Convertible note payable, net of discount   2,995
Total current liabilities 26,475 32,827
Operating lease liabilities, less current portion 3,722 3,932
Other long-term liabilities 36,434 33,750
Notes payable, less current portion 488  
Convertible note payable 3,150  
Total liabilities 70,269 70,509
STOCKHOLDERS’ DEFICIT    
Preferred stock — par value $0.001 per share, 15,000,000 shares authorized, none issued or outstanding
Common stock — par value $0.001 per share, 250,000,000 shares authorized, 48,987,189 shares and 48,471,446 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 49 48
Additional paid-in capital 216,376 215,207
Accumulated other comprehensive loss (51) (79)
Accumulated deficit (230,393) (226,229)
Total stockholders’ deficit (14,019) (11,053)
Total liabilities & stockholders’ deficit $ 56,250 $ 59,456